| 1 |
Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
Jennifer G. Robinson, Bettina S. Nedergaard, William John Rogers et al. · JAMA
|
13 May 2014 |
507 |
| 2 |
Anti-PCSK9 Monotherapy for Hypercholesterolemia
Michael J. Koren, Pernille Lundqvist, Michael A. Bolognese et al. · Journal of the American College of Cardiology
Open access |
29 Mar 2014 |
415 |
| 3 |
Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Kevin T. McVary, Claus G. Roehrborn, Jed C. Kaminetsky et al. · The Journal of Urology
|
24 Mar 2007 |
376 |
| 4 |
Sildenafil Citrate Improves Erectile Function and Urinary Symptoms in Men With Erectile Dysfunction and Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Randomized, Double-Blind Trial
Kevin T. McVary, William B. Monnig, Joseph L. Camps et al. · The Journal of Urology
|
11 Feb 2007 |
352 |
| 5 |
Determinants of Elevated Pulse Pressure in Middle-Aged and Older Subjects With Uncomplicated Systolic Hypertension
Gary F. Mitchell, Yves Lacourcière, Jean-Pascal Ouellet et al. · Circulation
Open access |
16 Sep 2003 |
325 |
| 6 |
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
Michael J. Koren, Patrick M. Moriarty, Seth J. Baum et al. · Nature Medicine
|
2022 |
235 |
| 7 |
Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients With Systolic Hypertension
Gary F. Mitchell, Joseph L. Izzo, Yves Lacourcière et al. · Circulation
|
25 Jun 2002 |
224 |
| 8 |
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
Vlad Ratziu et al. · Nature Medicine
Open access |
Oct 2021 |
222 |
| 9 |
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings
Murielle M. Véniant, Shu-Chen Lu, Larissa I. Atangan et al. · Nature Metabolism
Open access |
5 Feb 2024 |
214 |
| 10 |
Advanced glycation end-product cross-link breakersA novel approach to cardiovascular pathologies related to the aging process
George L. Bakris, A Bank, D KASS et al. · American Journal of Hypertension
|
Dec 2004 |
209 |
| 11 |
A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer
Channing Judith Paller, Xiquan Ye, Paulina Woźniak et al. · Prostate Cancer and Prostatic Diseases
Open access |
12 Jun 2012 |
186 |
| 12 |
Aortic Diameter, Wall Stiffness, and Wave Reflection in Systolic Hypertension
Gary F. Mitchell, Paul R. Conlin, Mark E. Dunlap et al. · Hypertension
Open access |
11 Dec 2007 |
183 |
| 13 |
Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia
Christie Mitchell Ballantyne, Joel Neutel, Anne Cropp et al. · The American Journal of Cardiology
Open access |
11 Feb 2015 |
171 |
| 14 |
Comparative Evaluation of [99mTc]Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials
Anne Marie Wallace, Linda K. Han, Stephen P. Povoski et al. · Annals of Surgical Oncology
Open access |
16 Mar 2013 |
115 |
| 15 |
Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors
Peter William Blumencranz, Pat W. Whitworth, Kenneth Deck et al. · The American Journal of Surgery
|
7 Sep 2007 |
105 |
| 16 |
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
Annette Magdalene Langer-Gould, Jessica B. Smith, Edlin G. Gonzales et al. · International Journal of Infectious Diseases
Open access |
5 Aug 2020 |
99 |
| 17 |
A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients
Edward M. Messing, Jason Gee, Daniel R. Saltzstein et al. · Cancer Prevention Research
Open access |
Feb 2012 |
96 |
| 18 |
A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide
Matthew R. Weir, Willa A. Hsueh, Shawna D. Nesbitt et al. · Journal of Clinical Hypertension
Open access |
5 Feb 2011 |
85 |
| 19 |
Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and Management
Jonathan Wade Goldman, Melody A. Mendenhall, Sarah R. Rettinger · The Oncologist
Open access |
29 Jul 2016 |
83 |
| 20 |
Tissue fixation security in transosseous rotator cuff repairs: A mechanical comparison of simple versus mattress sutures
Stephen S. Burkhart, Scott P. Fischer, Wesley M. Nottage et al. · Arthroscopy The Journal of Arthroscopic and Related Surgery
|
Dec 1996 |
81 |
| 21 |
The Efficacy and Safety of Low‐ and High‐ Dose Fixed Combinations of Irbesartan/Hydrochlorothiazide in Patients With Uncontrolled Systolic Blood Pressure on Monotherapy: The INCLUSIVE Trial
Joel M. Neutel, Elijah Saunders, George L. Bakris et al. · Journal of Clinical Hypertension
Open access |
Oct 2005 |
78 |
| 22 |
Bariatric surgery in patients older than 65 years is safe and effective
Brian B. Quebbemann, David R. Engstrom, T. Siegfried et al. · Surgery for Obesity and Related Diseases
|
25 Jun 2005 |
74 |
| 23 |
Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone Loss
James R. Berenson, Ori Yellin, Ralph Vincent Boccia et al. · Clinical Cancer Research
|
30 Sep 2008 |
71 |
| 24 |
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID ‐19, in Subjects With Renal Impairment
Sima S. Toussi, Joel M. Neutel, Jesús Navarro et al. · Clinical Pharmacology & Therapeutics
Open access |
17 Jun 2022 |
68 |
| 25 |
International Importance of Robust Breast Device Registries
Rodney D. Cooter, S. B. Barker, Sean Michael Carroll et al. · Plastic & Reconstructive Surgery
|
28 Jan 2015 |
65 |
| 26 |
Tadalafil Improved Erectile Function at Twenty‐Four and Thirty‐Six Hours After Dosing in Men With Erectile Dysfunction: US Trial
Jay M. Young, Robert Feldman, Stephen M. Auerbach et al. · Journal of Andrology
Open access |
2 May 2005 |
59 |
| 27 |
Efficacy and Safety of Coadministered Amlodipine and Atorvastatin in Patients With Hypertension and Dyslipidemia: Results of the AVALON Trial
Franz H. Messerli, George L. Bakris, René Ferrera et al. · Journal of Clinical Hypertension
Open access |
Aug 2006 |
57 |
| 28 |
Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration
Amir H. Kashani et al. · Stem Cell Reports
Open access |
3 Feb 2022 |
55 |
| 29 |
Lack of Effect of Fluticasone Propionate Aqueous Nasal Spray on the Hypothalamic-Pituitary-Adrenal Axis in 2- and 3-Year-Old Patients
Stanley Paul Galant, Isaac Reuven Melamed, Anjuli S. Nayak et al. · PEDIATRICS
|
Jul 2003 |
53 |
| 30 |
Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients
Joel M. Neutel · Current Medical Research and Opinion
|
9 Jul 2008 |
52 |
| 31 |
Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer
Aaron Spitz, Jay M. Young, Lois M. Larsen et al. · Prostate Cancer and Prostatic Diseases
Open access |
25 Oct 2011 |
52 |
| 32 |
Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study
Joel M. Neutel, David H.G. Smith, Michael A. Weber et al. · Journal of Clinical Hypertension
Open access |
Nov 2005 |
52 |
| 33 |
Telmisartan/Hydrochlorothiazide in Comparison with Losartan/Hydrochlorothiazide in Managing Patients with Mild-to-Moderate Hypertension
Joel M. Neutel, Thomas W Littlejohn, Steven G. Chrysant et al. · Hypertension Research
Open access |
2005 |
51 |
| 34 |
Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy
William E. Berger, Mark B. Abelson, P.J. Gomes et al. · Annals of Allergy Asthma & Immunology
|
Oct 2005 |
47 |
| 35 |
Social System Psychotherapy
Ε. Mansell Pattison · American Journal of Psychotherapy
|
Jul 1973 |
47 |
| 36 |
The Use of a Single‐Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo‐Controlled, Multicenter Study
Joel M. Neutel, William H. Bestermann, Eric M. Dyess et al. · Journal of Clinical Hypertension
Open access |
2009 |
46 |
| 37 |
Thioridazine plasma levels and clinical response
Louis A. Gottschalk, Robert Biener, Ernest Pascal Noble et al. · Comprehensive Psychiatry
|
Jul 1975 |
44 |
| 38 |
Use of an Olmesartan Medoxomil‐Based Treatment Algorithm for Hypertension Control
Joel M. Neutel, David H.G. Smith, Micheal A. Weber et al. · Journal of Clinical Hypertension
Open access |
Apr 2004 |
43 |
| 39 |
Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: Pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials
Yves Lacourcière, Joel M. Neutel, Helmut Schumacher · Clinical Therapeutics
|
Nov 2005 |
43 |
| 40 |
Efficacy and Safety of Treating Stage 2 Systolic Hypertension With Olmesartan and Olmesartan/HCTZ: Results of an Open‐Label Titration Study
Joseph L. Izzo, Joel M. Neutel, Tonous N Silfani et al. · Journal of Clinical Hypertension
Open access |
2007 |
43 |
| 41 |
Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study
Henry A. Punzi, Joel M. Neutel, Dean J. Kereiakes et al. · Therapeutic Advances in Cardiovascular Disease
|
2 Jun 2010 |
41 |
| 42 |
Hypertension Management: Rationale for Triple Therapy Based on Mechanisms of Action
Joel M. Neutel, David H.G. Smith · Cardiovascular Therapeutics
|
2 Nov 2012 |
41 |
| 43 |
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients
Peter J. Winkle, Steven R. Goldsmith, Michael J. Koren et al. · Cardiovascular Drugs and Therapy
Open access |
23 Apr 2022 |
40 |
| 44 |
The effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials
Philippe Gosse, Joel M. Neutel, Helmut Schumacher et al. · Blood Pressure Monitoring
|
11 May 2007 |
40 |
| 45 |
Pharmacology of cardiovascular chronotherapeutic agents
David J. Smith · American Journal of Hypertension
|
Sep 2001 |
40 |
| 46 |
A Randomized Trial Investigating the Efficacy and Safety of Water Soluble Micellar Paclitaxel (Paccal Vet) for Treatment of Nonresectable Grade 2 or 3 Mast Cell Tumors in Dogs
David M. Vail et al. · Journal of Veterinary Internal Medicine
Open access |
6 Mar 2012 |
40 |
| 47 |
Antihypertensive Efficacy of Irbesartan/HCTZ in Men and Women With the Metabolic Syndrome and Type 2 Diabetes
James R. Sowers, Joel M. Neutel, Elijah Saunders et al. · Journal of Clinical Hypertension
Open access |
Jul 2006 |
40 |
| 48 |
Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials
Bryan Williams, Yves Lacourcière, Helmut Schumacher et al. · Journal of Human Hypertension
|
19 Feb 2009 |
40 |
| 49 |
The role of combination therapy in the management of hypertension
Joel M. Neutel · Nephrology Dialysis Transplantation
|
19 May 2006 |
38 |
| 50 |
Oral insulin ( ORMD ‐0801) in type 2 diabetes mellitus: A dose‐finding 12‐week randomized placebo‐controlled study
Roy Eldor, Bruce H. Francis, Alexander Fleming et al. · Diabetes Obesity and Metabolism
|
25 Oct 2022 |
37 |